But our ocean’s health is in danger. How can the blue economy help restore and protect this vital planetary resource? Ahead of the 2022 UN Ocean Conference this June, we spoke with UN DESA’s ...

bluebird bio (NASDAQ:BLUE) lost ~37% in the premarket on Friday after the gene therapy developer announced its plans to become a privately held biotech as part of an M&A agreement with private ...

Short interest in bluebird bio Inc (NASDAQ:BLUE) decreased during the last reporting period, falling from 2.72M to 1.99M. This put 22.18% of the company's publicly available shares short.

Explore bluebird bio stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for BLUE. Bristol Myers Squibb Scoops Up Its Blood Cancer Drug Partner 2seventy Bio In $ ...

Shares of bluebird bio (NASDAQ:BLUE) continued their downward descent Monday in the wake of news that the company has agreed to be taken private by Carlyle Group (NASDAQ:CG) and SK Capital ...

bluebird bio stock opened at $4.08 on Friday. The firm has a market capitalization of $39.66 million, a P/E ratio of -0.11 and a beta of 0.68. The stock has a fifty day moving average price of $7. ...

bluebird bio (NASDAQ:BLUE – Get Free Report) had its target price dropped by analysts at Wells Fargo & Company from $40.00 to $5.00 in a note issued to investors on Monday,Benzinga reports.